Adenosine acts as a neuromodulator in the hippocampus essentially through activation of inhibitory A 1 receptors. Using single-cell PCR analysis, we found that CA1 pyramidal cells coexpress A 1 receptor mRNA together with that of another adenosine receptor, the A 3 receptor. As occurs for the A 1 receptor, Western blot analysis indicated that the A 3 receptor is also located in hippocampal nerve terminals. However, activation of A 3 receptors with its purportedly selective agonist Cl-IBMECA (0.1-10 mM) failed to affect hippocampal synaptic transmission or to modify the evoked release of glutamate or GABA. Also, blockade of A 3 receptors with MRS 1191 (5 mM) failed to affect either hypoxia-or ischemiainduced depression of hippocampal synaptic transmission. Activation of A 3 receptors also failed to control A 1 receptor function, as Cl-IBMECA (100 nM 
has been argued that A 3 receptors have an affinity for adenosine considerably lower (K i =1000 nM) than A 1 (K i =10 nM) and A 2A (K i =30 nM) receptors [GalloRodriguez et al., 1994] . This implies that the activation of A 3 receptors is essentially predicted to occur in stressful situations that lead to a marked increase in the extracellular concentration of adenosine [Jacobson, 1998] . However, more recent data indicate that adenosine is as potent on A 3 as on A 1 and A 2A receptors Schulte and Fredholm, 2001] .
Whether A 3 receptors might also control neuronal activity under nonstressful situations is not clear because the effects of A 3 receptor activation on neuronal activity at the cellular level have been poorly investigated. In the cerebral cortex, the A 3 receptor agonist IB-MECA inhibited synaptic transmission in a manner sensitive to an A 3 receptor antagonist [Brand et al., 2001 ]. In the hippocampus, A 3 receptor activation facilitates synaptic plasticity phenomena [Costenla et al., 2001 ] and increases neuronal activity through a protein kinase Adependent facilitation of postsynaptic calcium currents [Fleming and Mogul, 1997] , although A 3 receptors appear not to affect calcium-activated potassium currents [Dunwiddie et al., 1999] . In the hippocampus, A 3 receptor immuno-reactivity was identified in nerve terminals [Díaz-Hernández et al., 2002] and the activation of these putative presynaptic A 3 receptors inhibits both metabotropic glutamate group III receptor- [Macek et al., 1998 ] and adenosine A 1 receptor-mediated responses [Dunwiddie et al., 1997] .
In spite of these evidences for both presynaptic and postsynaptic A 3 receptor-mediated effects in the central nervous system, the density of A 3 receptors in the brain is rather low and the identification of A 3 receptors has mostly been accessed by whole-tissue PCR, which has revealed the presence of mRNA encoding for A 3 receptor in the hippocampus, cerebellum, and striatum [De et al., 1993; Dixon et al., 1996; Richardson et al., 2000] . However, in situ hybridization studies have questioned whether neurons in the brain expressed A 3 receptors [Rivkees et al., 2000] .
Thus, we now took advantage of single-cell PCR and combined biochemical and immunological techniques to test if hippocampal neurons are endowed with A 3 receptors. We tried to define the possible role of A 3 receptors in the hippocampus in nonstressful and in stressful situations, with particular attention to whether A 3 receptors control the predominant adenosine A 1 receptors.
MATERIALS AND METHODS

Single-Cell PCR
Sections 10 mm thick from male Wistar rats frozen brains were obtained with a cryostat, taken between À4.52 and À2.80 mm from Bregma, dehydrated in 100% ethanol, rehydrated gradually (50-100% ethanol), stained with Nissl stain (gives purple color to neurons), and dehydrated again with xylene according to Luo et al. [1990] . The required neurons from CA1 area of the hippocampus were laser microdissected with an Arcturus LCM 210 PixCell II system with a spot size of 7.5 mm. The total RNA was then extracted according to Absolutely RNA Nanoprep Kit instructions from Stratagene and subjected to reverse transcription (RT) and cDNA amplification. For RT and cDNA amplification, we used the 3 0 -end amplification (TPEA) protocol previously described by Dixon et al. [1998] . All the primers used were from Perkin Elmer Applied Biosystems (United Kingdom). The amplified samples (5 ml aliquots) were used for subsequent gene-specific PCR after cDNA purification according to QIAquick spin handbook (QIAGEN). For gene-specific PCR, the samples of the preamplified cDNA were subjected to 45 rounds of PCR in 20 mL of 45 mM Tris-HCl (pH 8.1), 12.5% (w/v) sucrose, 12 mM (NH 4 ) 2 SO 4 , 3.5 mM MgCl 2 , and 0.5 mM deoxynucleotide triphosphates, with 100 ng of the forward and reverse primer. The cycling conditions were 2.5 min at 921C (denaturation), 1.5 min at 601C (annealing), and 1 min at 721C (extension). After amplification, the products were separated on 2% agarose gels and visualized using ethidium bromide. The primers used are listed in Table 1 . In all experiments, positive controls for the primers used were electrophoresed in parallel to the gene-specific assays. These routinely contained cDNA derived from 1 ng of whole-brain total RNA.
Western Blot Analysis in Nerve Terminal Membranes
The Western blot analysis of A 3 receptors was carried out in membranes from a Percoll-purified synaptosomal fraction, prepared as previously described [Cunha et al., 1996] . After determining the amount of protein [Spector, 1978] , each sample was diluted with an equal volume of 2 Â SDS-PAGE sample buffer (62.5 mM Tris-HCl pH 6.8, 25% (v/v) glycerol, 2% (w/v) SDS, 0.01% (w/v) bromophenol blue, 5% (v/v) b-mercaptoethanol). These diluted samples and the prestained molecular weight markers (Amersham) were separated by SDS-PAGE (10% resolving gel and 4% concentrative gel) under reducing conditions and electrotransferred to polyvinylidene difluoride membranes (0.45 mm from Amersham). After blocking for 2 h at room temperature with 5% milk in Tris-buffered saline (140 mM NaCl, 20 mM Tris), pH 7.6 containing 0.1% Tween 20 (TBS-T), the membranes were incubated overnight at 41C with a rabbit anti-adenosine A 3 receptor affinity purified polyclonal antibody (Chemicon, 1 mg/mL, 1:1000 dilution). After four 10-min washes with TBS-T containing 0.5% milk, the membranes were incubated with the alkaline phosphatase-conjugated anti-rabbit secondary antibody (1:5000 dilution from Amersham) in TBS-T containing 1% milk during 90 min at room temperature. After five 10-min washes in TBS-T containing 0.5% milk, the membranes were incubated with Enhanced Chemi-Fluorescence (ECF) for 5 min and then analyzed densitometrically with a Storm (Molecular Devices).
Electrophysiological Recordings in Hippocampal Slices
Male Wistar rats (5-6 weeks old), handled according to the European guidelines (86/609/ EEC), were decapitated after halothane anesthesia, and the hippocampus dissected free in ice-cold Krebs solution of the following composition (mM): NaCl 124, KCl 3, NaHCO 3 26, Na 2 HPO 4 1.25, MgSO 4 1, CaCl 2 2, glucose 10, gassed with a 95% O 2 + 5% CO 2 mixture. Slices were cut (400 mm) with a McIlwain tissue chopper and allowed to recover for at least 1 h in a resting chamber within the same gassed medium at room temperature (20-251C). Individual slices were transferred to a submersion recording chamber (1 mL capacity) and continuously superfused at a rate of 3 mL/min with the same gassed Krebs solution at 30.51C or at 321C for hypoxia and ischemia experiments. Stimulation was delivered to the Schaffer collateral/ commissural fibers through a bipolar concentric wire electrode and rectangular pulses of 0.1 ms duration were applied every 15 sec. The initial intensity of the stimulus was chosen to elicit a response of about 50% of maximal field excitatory postsynaptic potencial (fEPSP) amplitude. The fEPSPs were recorded extracellularly from CA1 stratum radiatum by use of micropipettes filled with NaCl 4 M with 2-4 MO resistance, and displayed on a Tektronix digitizing oscilloscope. The averages of eight consecutive responses were obtained, graphically plotted, and recorded for further analysis with the LTP software [Anderson and Collingridge, 1997] . The slopes and amplitudes of the averaged fEPSPs were determined and then averaged during the predrug control, drug superfusion, and postdrug washout period; at least six responses were included in each average. Compounds were added through the superfusion solution.
The hypoxic insult consisted of changing the superfusion tube to a Krebs solution in which the bubbling gas was 95% N 2 +5% CO 2 for 4 min and the maximum depression in amplitude of the fEPSPS registered. The ischemic insult was achieved by changing for 10 min the superfusion tube to a Krebs solution, but where glucose was not present, gassed with 95% N 2 +5% CO 2 . After the challenging periods, the superfusion solutions were changed back to normal Krebs solution. The data were analyzed as mean percentage change in response amplitude when compared with responses obtained during the control period. The values are shown as mean 7 SEM of n (number of experiments), except where otherwise indicated. The significance of differences was evaluated by the paired Student's t test. P values less than 0.05 were considered significant.
Neurotransmitter Release from Hippocampal Nerve Terminals
The evoked release of [ 3 H]glutamate was carried out as previously described [Lopes et al., 2002] , and the release of [ 3 H]GABA was performed as described by Cunha and Ribeiro [2000] . Synaptosomes were purified by sucrose/Percoll gradients, loaded with [
]GABA, and placed over GF/B filters under superfusion. The synaptosomes were stimulated twice with 20 mM K + for 30 sec (for glutamate release) or for 2 min (for GABA release) with a time span of 9-16 min. Drugs were added 2 min before the second stimulation period, and their effect was evaluated by changes in the evoked release of tritium measured in the effluent.
Membrane Binding Experiments
Either membranes or synaptosomes were prepared as previously described [Lopes et al., 1999] . Competition curves of the adenosine A 1 receptor antagonist [ The binding reactions were stopped by vacuum filtration through glass fiber filters (filtermats to receptor binding from Skatron) using a Skatron 1719 cell harvester, and the tubes and filters washed with 5 mL of the respective ice-cold incubation buffer. The filters were then placed in scintillation vials and 4 mL of scintillation liquid (Optiphase HiSafe Scintillation Cocktail) added. Radioactivity was determined after at least 12 h with a counting efficiency of 55-60%. The protein concentration was determined using the Bio-Rad protein assay [Bradford, 1976] . The IC 50 values were converted into K i values upon nonlinear fitting of the semilogaritmic curves derived from the competition curves. An F test (P o 0.05) was used to determine whether the competition curves were best fitted by a one or two independent binding site equation. The K i values are presented as mean with 95% confidence interval (CI). ), on a 129/B6D2 background [Salvatore et al., 2000] (generation F2 or F3), were anesthetized with carbon dioxide and thereafter decapitated. The brains were immediately dissected out, frozen on dry ice, and stored at À801C until used. Using a cryostat, the levels of Bregma 1.42 to 0.50, À0.34 to À0.58, À1.70 to À2.18, and À7.08 to À7.48 mm [Franklin and Paxinos, 1997] were sectioned into 10-mm-thick frontal sections, which were thaw mounted on polylysine-coated glass slides (Menzel-Gläser, Germany). Slides were stored at À201C until used.
Autoradiographic Experiments
Receptor autoradiography was performed by drying the sections at room temperature for 60 min and preincubating at 371C in 170 mM Tris-HCl, 2 U/ mL adenosine deaminase (ADA) and 1 mM EDTA, pH 7.4, for 30 min. After washing twice at room temperature in 170 mM Tris-HCl with 1 mM MgCl 2 (pH 7.4) for 10 min, the sections were incubated for 2 h at room temperature in a solution containing 170 mM Tris-HCl (pH 7.4), 1 mM MgCl 2 , 2 U/mL ADA, and 0.2, 0.5, 1, 2, 5, or 10 nM [ 3 H]DPCPX, and for nonspecific binding, 20 mM R-PIA. The slides were then washed twice in 170 mM Tris-HCl (pH 7.4) at 41C for 5 min and dipped three times in ice-cold distilled water. Slides were dried overnight in front of a fan at 41C. Sections were then apposed to Hyperfilm-3 H (Amersham) together with tritium standards (Amersham) for 3 weeks. The optical density was measured using a computer program (MCID, Imaging Research, St. Catherines, Canada) , and values were converted to fmol/mg grey matter using the tritium standards. The specific binding was achieved by subtracting the nonspecific binding from the total binding values.
-cyclopentyladenosine (CPA), and 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) were purchased from Sigma-RBI (Natick, USA). Taking advantage of laser dissection, which allows isolated cells to be taken from heterogeneous tissue with little contamination from the surroundings, we dissected single pyramidal neurons from the CA1 area of the hippocampus and subjected them to genespecific PCR. In addition to the adenosine receptors mRNAs, we also tested NMDAR1, a marker of pyramidal cells, GFAP, an astrocyte marker, and one intronic marker to ensure the quality of the RT reaction. From 10 cells analyzed that were NMDAR1-positive, five of them showed coexpression of mRNA encoding for adenosine A 1 and A 3 receptors (see Fig. 1A ). We are aware that contamination from, for example, microglial processes cannot be excluded.
Given this apparent coexpression of A 1 and A 3 receptor mRNA in pyramidal cells, we looked for the presence of A 3 receptors where A 1 receptors are most abundant (i.e., in nerve terminals). As illustrated in Figure 1B , there was a clear A 3 receptor-like immunoreactivity that displayed an electrophoretic mobility corresponding to an apparent molecular weight of 44 kDa, similar to the expected molecular weight of the rat A 3 receptor [Christofi et al., 2001 ]. This signal was not observed either when the primary antibody was not added or when this experiment was carried out in the presence of 1 mg of the immunizing peptide.
Effects of A 3 Receptors on Synaptic Transmission and Neurotransmitter Release
The purportedly more selective adenosine A 3 receptor agonist available, Cl-IBMECA, did not affect synaptic transmission in the concentration range tested (10 nM to 10 mM) (Fig. 2) . This lack of effect of A 3 receptor activation could be caused by opposite effects on glutamate and GABA release. We therefore evaluated the effect of A 3 receptor activation on glutamate and GABA release from hippocampal nerve terminals. Because we had previously observed that Cl-IBMECA might activate adenosine A 1 receptors [Costenla et al., 2001 ], the following experiments were conducted under blockade of A 2A and A 1 receptors to eliminate possible nonselective responses, using the A 1 receptor antagonist DPCPX (50 nM) and the A 2A receptor antagonist ZM 241385 (50 nM). Cl-IBMECA (100 nM and 10 mM) had no effect on glutamate release compared to control conditions (Table 2) . Likewise, 100 nM and 1 mM Cl-IBMECA failed to modify the evoked release of GABA from superfused hippocampal synaptosomes (see Table 2 ).
To test whether A 3 receptors might be tonically activated in stressful situations, we tested the consequences of blocking A 3 receptors on synaptic transmission during a hypoxic insult lasting 4 min. As illustrated in Figure 3A , the removal of oxygen causes a marked inhibition of synaptic transmission that recovers completely once oxygen is reintroduced. It is also evident from Figure 3A that the hypoxia-induced depression of fEPSPs was similar in both the absence and presence of the A 3 receptor antagonist MRS 1191 (5 mM). The consequences of blocking A 3 receptors were also tested in an ischemic situation applied for 10 min. But again, the ischemia-induced depression of fEPSPs was similar in the absence and in the presence of MRS 1191 (5 mM) (Fig. 3B) . In control experiments, we confirmed that two consecutive hypoxic or ischemic insults caused a similar depression of fEPSPs in the absence of drugs (data not shown).
Effect of Adenosine A 3 Receptor Activation on A 1 Receptor Function
One possibility to reconcile the evidence for the neuronal location of A 3 receptors with the lack of effect of A 3 receptors on synaptic transmission and neurotransmitter release would be that the A 3 receptors mostly fulfilled a fine-tuning role, controlling the action of other neuromodulatory systems [Sebastião and Ribeiro, 2000] . Thus, we investigated if A 3 receptors could control A 1 receptor function, as previously proposed [see Dunwiddie et al., 1997] . To carry out this study, we first had to evaluate the real selectivity of the most selective A 3 receptor agonist, Cl-IBMECA, against hippocampal A 1 receptors, because the initial selectivity of this ligand has mostly been determined using heterologously expressed adenosine receptors and previous studies have claimed that Cl-IBMECA could bind and activate A 1 receptors in the rat brain [Rivkees et al., 2000; Costenla et al., 2001] .
We performed displacement binding curves of the adenosine A 1 receptor agonist [ . These experiments were carried out in hippocampal synaptosomes to preserve intracellular transducing pathways eventually required for the interaction to occur [Lopes et al., 1999] . In control conditions (i.e., with no Cl-IBMECA), the displacement binding curve by CPA (0.1 nM to 1 mM) was fitted best by a single binding site equation with a K i of 1.4 nM (95% confidence interval: 0.9-2.2 nM, n ¼ 6) (see Fig. 4C ). Cl-IBMECA (100 nM) did not significantly (P 4 0.05) change the displacement binding curve of CPA, resulting in a K i of 2.3 nM (95% confidence interval: 1.7-3.2 nM, n ¼ 6) (see Fig. 4C ).
Because these experiments in synaptosomes were conducted in a time scale of minutes and the A 3 /A 1 receptor interaction could take longer to be measured, we compared by autoradiography the binding of the selective A 1 receptor ligand [ 3 H]DPCPX in sections from wild-type and A 3 receptor knock-out mice. Using mutant mice in which the gene for A 3 receptor was knocked out [Salvatore et al., 2000] or reduced by half (A 3 R (+/À) ), we observed that no differences existed in the binding of DPCPX to the hippocampus, compared to wild-type mice (Fig. 5) . There was also no difference in DPCPX binding in any other region studied (hippocampus, cortex, cerebellum, and striatum; data not shown). The B max values in the CA1 region for (0.36-0.82), and 0.50 (0.30-0.71) nM, respectively (n ¼ 6 for all).
Because the A 3 /A 1 interaction was reported to occur at the functional rather than the molecular level [Dunwiddie et al., 1997] , we used extracellular electrophysiological recordings from CA1 area of rat hippocampal slices to probe this interaction. We compared the effect of the stable adenosine analogue, 2-chloroadenosine (CADO) in the absence and in the presence of Cl-IBMECA. CADO (1 mM) alone caused an 86.3 7 4.5% (n ¼ 3) inhibition of fEPSP amplitude, an effect caused by A 1 receptor activation [de Mendonça and Ribeiro, 1990] . In the presence of Cl-IBMECA (100 nM), CADO (1 mM) still reduced by 79.0 7 6.5% (n ¼ 3) the fEPSP amplitude (Fig. 6) , a value similar (P 4 0.05) to that caused by the first application of CADO (1 mM) alone in the same slices.
In control experiments, we confirmed that two successive applications of CADO (1 mM) alone elicited a similar inhibition of fESPS amplitude (the ratio between CADO inhibitory effect elicited by the second and first application was 1.02 7 0.03, n ¼ 2). 
DISCUSSION
The present results provide evidence that adenosine A 3 receptors are expressed in hippocampal neurons and that they are located in hippocampal nerve terminals. However, these presynaptic A 3 receptors do not have a direct effect on synaptically evoked excitatory responses, as observed previously in the same preparation [Dunwiddie et al., 1997] and as reported to occur in the cortex [Brand et al., 2001] . Even in situations of cellular stress, such as hypoxia or ischemia, when the extracellular levels of adenosine rise [reviewed by Fredholm, 1996; Cunha, 2001 ], no effect of endogenous adenosine-activating A 3 receptors could be detected in the control of synaptic transmission. Also, no effects resulting from A 3 receptor activation could be monitored in the evoked release of glutamate or GABA from synaptosomes. These results are in complete agreement with the recent finding that adenosine has no effect on excitatory neurotransmission in the hippocampus of mice that lack the adenosine A 1 receptor [Johansson et al., 2001] .
This lack of evident effects of presynaptic A 3 receptors also appears at odds with the previously reported ability of A 3 receptors to facilitate long-term potentiation (LTP) and long-term depression (LTD) [Costenla et al., 2001] . But taking the data together, it is likely that the control by A 3 receptors of synaptic plasticity might result from the activation of postrather than presynaptic A 3 receptors. This would reconcile the presently observed expression of A 3 receptor mRNA in hippocampal pyramidal neurons with the previously reported ability of A 3 receptors to facilitate postsynaptic calcium currents [Fleming and Mogul, 1997] . Further work is required to characterize these postsynaptic A 3 receptors in the hippocampus.
Thus, the possible role of the identified presynaptic A 3 receptors in the rat hippocampus remains essentially elusive. It is possible that presynaptic A 3 receptors might be especially important in a particular subtype of hippocampal nerve terminals. In this respect, it has been reported that A 3 receptor activation has a minor role in the control of serotonin release in the hippocampus [Okada et al., 1997] , but to the best of our knowledge no information is available on the ability of A 3 receptors to control noradrenaline, dopamine, or acetylcholine release in the hippocampus. Another possible role for these presynaptic A 3 receptors might be their ability to act as fine-tuning neuromodulators [Sebastião and Ribeiro, 2000] . In fact, A 3 receptors have been described to inhibit the actions of group III presynaptic metabotropic glutamate receptors in the hippocampus [Macek et al., 1998 ], to inhibit adenosine polyphosphate-mediated presynaptic calcium transients [Diíz-Hernández et al., 2002] , and also to inhibit adenosine A 1 receptor-mediated responses in the rat hippocampus [Dunwiddie et al., 1997] .
We explored this possible role of A 3 receptors to attenuate A 1 receptor-mediated responses [Dunwiddie et al., 1997] and we provide the required structural background for this interaction to occur (i.e., the presence of mRNA for both receptor subtypes in the same cell), as suggested by PCR analysis of a single CA1 neuron. However, we found no apparent control by A 3 receptors of A 1 receptor-mediated inhibition of excitatory synaptic transmission or of the affinity of A 1 receptors, as shown by binding studies. Also, the mice lacking A 3 receptors displayed no differences in the number or affinity of A 1 receptors, suggesting that no long-term control by A 3 receptors of the density of A 1 receptors takes place. The concentration of the A 3 receptor agonist Cl-IBMECA used in the present study was lower than that used in previous studies because recent data show a lack of selectivity of A 3 receptor agonists over A 1 receptors [Rivkees et al., 2000; Costenla et al., 2001] . We confirmed that Cl-IBMECA binds to A 1 receptors even at low nanomolar concentrations. This obviously compromises the possibility of any eventual A 1 /A 3 receptor interaction to be fully investigated and casts strong doubts on whether the previously reported A 3 /A 1 receptor interaction might result from the lack of selectivity of the A 3 receptor ligands available.
One of the key questions raised by the present results is the usefulness of the A 3 receptor ligands, particularly Cl-IBMECA, to study A 3 receptormediated effects. The initial selectivity essays of Cl-IBMECA for A 3 receptors versus A 1 receptors were conducted in cortical tissue [Kim et al., 1994] , which might behave differently [cf. Brand et al., 2001 and present data] . Also, the fact that these ligands were synthesized based upon their potency in inhibiting adenylate cyclase in heterologous expression systems [Kim et al., 1994] limits the direct comparison of the obtained parameters to native tissues, as most of the evidence seems to indicate that A 3 receptors in the brain might not couple to adenylate cyclase but rather to protein kinase C [Abbracchio et al., 1995; Dunwiddie et al., 1997; Macek et al., 1998 ]. Thus, the real selectivity of the currently available A 3 receptor ligands against native adenosine receptors remains to be fully evaluated, and their use in physiological experiments in native tissue must be carefully evaluated.
In conclusion, A 3 receptors are present in the hippocampus, particularly in nerve terminals, and colocalized with A 1 receptors in pyramidal neurons. The present data suggest that no interaction between these two receptors subtypes exist and that A 3 receptors do not affect synaptic transmission (basal or in stressful conditions) or control glutamate or GABA release. That the known A 3 receptor ligands bind A 1 receptors represents a limitation for conclusive studies. The definititive answer to the function of A 3 receptors has to wait for reliable ligands and reliable functional assay to be used for the pharmacological characterization of A 3 receptor ligands vis-à-vis native A 3 receptors.
